UK Independent. Sourced. Primary. · Est. 2024
Home Before You Before You Buy Guardian 1821 Critical Illness: Cancer Definitions, Survival Period and What to Check
Before You

Before You Buy Guardian 1821 Critical Illness: Cancer Definitions, Survival Period and What to Check

Guardian 1821 Critical Illness: cancer definition, early-stage coverage, survival period, children's CI, partial payments. Real policy analysis.

CT
Chandraketu Tripathi
Finance Editor, Kaeltripton
Published 26 Jun 2026
Last reviewed 26 Jun 2026
✓ Fact-checked
Before You Buy Guardian 1821 Critical Illness: Cancer Definitions, Survival Period and What to Check

Illustrative image. AI-generated and does not depict real people, places or events.

Advertisement

Before You Buy: The Kael Tripton Verdict

Guardian 1821 was founded in 2018 specifically to address identified gaps in standard UK critical illness cover. It has three primary structural differentiators: (1) no survival period -- Guardian pays on qualifying diagnosis without a 10 or 14-day survival requirement; (2) early-stage cancer coverage -- Guardian covers carcinoma in situ, low-grade prostate cancer, early thyroid cancer and other early-stage diagnoses as partial payments; (3) the broadest children's CI conditions list in the UK market. Guardian is exclusively adviser-distributed. For buyers who specifically want maximum cancer definition breadth including early-stage, or maximum children's CI scope, Guardian is the market benchmark.

Key Facts
FCA RegisterGuardian Financial Services Limited -- FRN 781367. UK-incorporated. FSCS protected.
No Survival PeriodPays on qualifying diagnosis. No 10-day or 14-day survival requirement.
Early Cancer CoverCovers carcinoma in situ, low-grade prostate cancer, early thyroid cancer as partial payments.
Children's CIBroadest children's CI conditions list in the UK market.
Partial PaymentsConditions at lower severity levels pay percentage of sum insured.
DistributionExclusively adviser-distributed. IFA engagement required.
Founded2018. Specifically designed to close gaps in standard UK CI.
Market BenchmarkReference product for CI definition breadth among specialist advisers.

Cancer: the condition driving 60-70% of CI claims and where definitions diverge most

Cancer accounts for 60-70% of all adult critical illness claims in the UK. The cancer definition in your CI policy determines whether your specific diagnosis at your specific stage triggers a payment. All standard UK CI policies cover invasive cancer meeting ABI minimum severity criteria. Where they diverge significantly is on early-stage conditions: carcinoma in situ (non-invasive cancer cells), low-grade prostate cancer (Gleason score below 7), certain early thyroid cancers, and ductal carcinoma in situ (DCIS) of the breast.

Under standard ABI definitions, these early-stage conditions pay nothing. Guardian 1821 covers them as partial payments. Royal London covers 60+ early-stage cancers under partial payment structures. Vitality's severity-based model includes partial payments for early-stage diagnoses. For anyone with a family history of breast, prostate, or thyroid cancer, the cancer definition is the single most important policy comparison point.

The survival period: what it means and why 10 days is better than 14

Standard UK CI policies require the insured person to survive a specified period after diagnosis before the lump sum is payable. Standard periods are 10 or 14 days. If the insured person dies within the survival period, the CI policy does not pay -- the appropriate coverage for this scenario is life insurance, not CI. Aviva and Royal London use 10-day survival periods on their current individual CI products. Guardian 1821 has no survival period at all -- the lump sum is payable on qualifying diagnosis regardless of subsequent survival. In edge cases where prognosis is very short, these differences are meaningful.

Children's critical illness benefit: included and how it works

Most major UK CI policies include children's CI benefit at no additional cost. This covers the insured person's children (by birth, adoption, or step-relationship) for a defined list of conditions, paying a percentage of the adult sum insured or a capped amount -- Aviva pays the lower of 50% or £25,000; Royal London pays the lower of 25% or £25,000. The children's CI claim is a partial payment -- the adult policy continues in full after the claim. In 2024, Aviva paid over £7.6 million in children's CI claims across 361 families, with childhood cancer as the most common qualifying diagnosis.

Partial payments: how modern CI policies extend coverage beyond all-or-nothing

Traditional CI paid the full sum insured or nothing. Partial payment structures -- now offered by Guardian, Royal London, Vitality, and others -- pay a percentage of the sum insured for conditions at lower severity thresholds. A partial payment for carcinoma in situ (25% of sum insured at Royal London) does not extinguish the main policy -- the full sum remains available for a future full-definition qualifying event. For buyers who want financial protection at earlier stages of serious conditions, partial payment structures provide coverage that standard ABI-minimum policies do not.

Five things to check before you buy Guardian 1821 Critical Illness

  1. Cancer definition: Request the specific cancer definition from Guardian 1821 Critical Illness's current policy conditions. Understand exactly which cancers pay the full sum insured, which pay a partial amount, and which generate no payment.
  2. Survival period: Confirm the current survival period -- 10 days, 14 days, or none (Guardian 1821 only). Understand the implications for worst-case prognosis scenarios where this distinction is material.
  3. Children's CI terms: Verify the specific conditions covered, the payment percentage or capped amount, and whether the adult policy continues in full after a children's CI claim.
  4. Non-disclosure risk: Disclose all pre-existing conditions and relevant family history at application. Non-disclosure is the primary reason CI claims are declined -- not the policy definitions.
  5. Sum insured level: A UK benchmark for CI sum insured is 3 to 5 times annual salary. Consider: mortgage balance, income replacement for the expected recovery period, and any specific financial obligations a serious diagnosis would generate.

Critical illness vs income protection: different products for different financial risks

Critical illness cover and income protection are frequently discussed together but address different financial risks. Understanding the distinction before purchasing either prevents the error of buying the wrong product for your actual protection need.

Critical illness cover pays a tax-free lump sum on qualifying diagnosis. It does not depend on whether you are working, earning, or unable to work. A CI policyholder diagnosed with cancer who continues working through chemotherapy receives the full CI lump sum regardless of their earnings. The lump sum can be used for any purpose -- paying off a mortgage, funding private treatment, making home adaptations, replacing a partner's lost income, or maintaining a business through a period of reduced capacity.

Income protection pays a monthly benefit during the period you are genuinely unable to work due to illness or injury. It depends on actual incapacity -- a CI diagnosis that does not prevent you from working does not trigger income protection. IP replaces lost monthly income; CI provides capital for the larger financial reorganisation that a serious diagnosis may require.

The combination of both products provides the most comprehensive protection: CI addresses the capital-sum financial needs (mortgage payoff, major expenditure, treatment access) while IP addresses the ongoing monthly income replacement need during the incapacity period. For most working adults with significant financial commitments, both products serve complementary purposes that neither addresses alone.

How much critical illness cover do you need? A calculation framework

A UK benchmark for CI sum insured is 3 to 5 times annual salary. The appropriate level for any individual depends on the specific financial obligations a serious diagnosis would generate:

Mortgage balance: The most common use of CI payment is mortgage settlement. A CI diagnosis that prevents sustained employment for 2 to 5 years could result in mortgage default without either income protection covering payments or CI clearing the balance. The mortgage balance is the most quantifiable CI need.

Income replacement gap: If income protection covers 65% of pre-incapacity earnings, CI can fund the 35% gap or cover the income protection deferred period. For professionals whose income would fall significantly during a recovery period even if they return to work, CI provides the capital to manage that transition.

Treatment and adaptation costs: Private cancer treatment not available on the NHS (targeted therapies, immunotherapy, clinical trials) can cost £50,000 to £150,000 per year. Home adaptations following stroke or serious neurological condition can cost £20,000 to £80,000. The CI lump sum funds these costs where health insurance limits are exhausted or specific treatments are excluded.

Childcare and family support: A serious diagnosis affecting the primary carer or earner has financial implications beyond the individual -- childcare costs, family support, potential partner career disruption. The CI lump sum can address these downstream costs that income protection does not cover.

Joint vs separate CI policies: which provides better value?

Critical illness cover can be purchased as a joint policy covering two individuals, or as two separate single-life policies. The choice has material financial implications.

A joint critical illness policy pays once -- on the first qualifying CI claim from either insured person -- and then terminates. If one partner is diagnosed with cancer and claims the CI lump sum, the other partner's future CI risk is no longer covered. For couples whose joint financial obligations (mortgage, children's expenses) are not fully addressed by a single CI payment, a joint policy leaves a coverage gap after the first claim.

Two separate single-life CI policies cost more in combined premiums than a single joint policy, but each pays independently. If Partner A is diagnosed with cancer and claims, Partner A's policy pays and terminates; Partner B's policy continues in full with the same sum insured available for any future qualifying diagnosis on Partner B. For couples with a mortgage where both partners' continuing incapacity risk needs to be covered, two separate policies provide more complete protection than a joint policy at higher total premium cost.

The joint policy is more cost-effective for couples whose primary CI concern is a single event creating a specific financial need (clearing a mortgage) rather than ongoing individual coverage post-first claim. Analyse the specific financial obligations and protection need before choosing between joint and individual structures.

Editorial disclaimer: Kael Tripton is an independent editorial publisher. We do not receive commission from any provider featured. This is editorial analysis only, not a personal recommendation. Always verify against the current IPID and policy wording before purchasing.

Frequently Asked Questions

Why does Guardian have no survival period?

Guardian 1821 removed the survival period from its CI product, meaning the lump sum is payable on a qualifying diagnosis regardless of how long the insured person survives after that diagnosis. Standard CI policies (Aviva 10 days, Royal London 10 days, many others 14 days) do not pay if the insured dies within the survival window. Guardian's position is that the financial impact of a serious diagnosis begins at diagnosis, not 10 or 14 days later, and that the most severe diagnoses -- where survival beyond 10 days is uncertain -- are precisely where financial support is most needed. This is the single most consequential difference between Guardian and all standard market CI products.

How does Guardian cover early-stage cancers?

Guardian 1821 covers early-stage cancers as partial payments within its CI product. Specifically, Guardian covers: carcinoma in situ (non-invasive cancer); low-grade prostate cancer at specified staging criteria; early-stage thyroid cancer; ductal carcinoma in situ (DCIS) of the breast. These conditions receive partial lump sum payments -- a percentage of the sum insured -- rather than zero. The partial payment does not extinguish the main policy: a Guardian policyholder who receives a partial payment for carcinoma in situ retains the full sum insured for a future qualifying invasive cancer claim. For buyers with family history of breast, prostate, or thyroid cancer where early detection is a plausible scenario, Guardian's early-stage coverage is the most comprehensive in the UK standard market.

Is Guardian 1821 available without an IFA?

Guardian 1821 distributes exclusively through FCA-registered independent financial advisers and protection specialists. It is not available for direct purchase. To access Guardian CI, engage an IFA with Guardian on their panel. The adviser can compare Guardian's no-survival-period, early-stage cancer coverage, and children's CI breadth against Aviva, Royal London, Zurich, and Vitality SIC in a like-for-like comparison alongside premium at your specific profile. For the most comprehensive CI cover available in the UK market, particularly on cancer definitions, Guardian 1821 is the reference product that advisers benchmark against.


Sources

FCA Financial Services Register (register.fca.org.uk) • Insurer published IPIDs and policy conditions • ABI (abi.org.uk) • Financial Ombudsman Service (financial-ombudsman.org.uk)

Advertisement

Editorial Disclaimer

The content on Kaeltripton.com is for informational and educational purposes only and does not constitute financial, investment, tax, legal or regulatory advice. Kaeltripton.com is not authorised or regulated by the Financial Conduct Authority (FCA) and is not a financial adviser, mortgage broker, insurance intermediary or investment firm. Nothing on this site should be construed as a personal recommendation. Rates, figures and product details are indicative only, subject to change without notice, and should always be verified directly with the relevant provider, HMRC, the FCA register, the Bank of England, Ofgem or other appropriate authority before any financial decision is made. Past performance is not a reliable indicator of future results. If you require regulated financial advice, please consult a qualified adviser authorised by the FCA.

CT
Chandraketu Tripathi
Finance Editor · Kaeltripton.com
Chandraketu (CK) Tripathi, founder and lead editor of Kael Tripton. 22 years in finance and marketing across 23 markets. Writes on UK personal finance, tax, mortgages, insurance, energy, and investing. Sources: HMRC, FCA, Ofgem, BoE, ONS.

Stay ahead of your money

Free UK finance guides, rate changes and money-saving tips — straight to your inbox. No spam, unsubscribe anytime.

Read More

Get Kael Tripton in your Google feed

⭐ Add as Preferred Source on Google